Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry

Retrovirology

Volumn 3, Issue , 2006, Pages

  Bourgeois, Rachel ^a   Mercier, Johanne ^b   Paquette Brooks, Isabelle ^b   Cohen, Éric A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; LUCIFERASE; MONOMER; PROTEIN CD4; PROTEIN CD4 RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL FUSION; CELL SURFACE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; GENE DISRUPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; LYMPHOCYTE; MONOCYTE; MUTANT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; TARGET CELL; VIRUS CELL INTERACTION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANTIGENS, CD4; CELL LINE; DIMERIZATION; HIV-1; HUMANS; MEMBRANE FUSION; MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33746659382     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-31     Document Type: Article

References (27)

1. Doms RW, Trono D: The plasma membrane as a combat zone in the HIV battlefield. Genes Dev 2000, 14:2677-2688.
2. Miceli MC, Parnes JR: Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol 1993, 53:59-122.
3. Lynch GW, Sloane AJ, Raso V, Lai A, Cunningham AL: Direct evidence for native CD4 oligomers in lymphoid and monocytoid cells. Eur J Immunol 1999, 29:2590-2602.
4. Moldovan MC, Yachou A, Levesque K, Wu H, Hendrickson WA, Cohen EA, Sékaly RP: CD4 dimers constitute the functional component required for T cell activation. J Immunol 2002, 169:6261-6268.
5. Moldovan MC, Sabbagh L, Breton G, Sékaly RP, Krummel MF: Triggering of T Cell Activation via CD4 Dimers. J Immunol 2006, 176:5438-5445.
6. Matthias LJ, Yam PT, Jiang XM, Vandegraaff N, Li P, Poumbourios P, Donoghue N, Hogg PJ: Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol 2002, 3:727-732.
7. Lynch GW, Slaytor EK, Elliott FD, Saurajen A, Turville SG, Sloane AJ, Cameron PU, Cunningham AL, Halliday GM: CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers. Exp Dermatol 2003, 12:700-711.
8. Li S, Satoh T, Korngold R, Huang Z: CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design. Immunol Today 1998, 19:455-462.
9. Veillette A, Bookman MA, Horak EM, Samelson LE, Bolen JB: Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p561ck. Nature 1989, 338:257-259.
10. Briant L, Robert-Hebmann V, Sivan V, Brunet A, Pouyssegur J, Devaux C: Involvement of extracellular signal-regulated kinase module in HIV-mediated CD4 signals controlling activation of nuclear factor-kappa B and AP-1 transcription factors. J Immunol 1998, 160:1875-1885.
11. Wu H, Kwong PD, Hendrickson WA: Dimeric association and segmental variability in the structure of human CD4. Nature 1997, 387:527-530.
12. Langedijk JP, Puijk WC, van Hoorn WP, Meloen RH: Location of CD4 dimerization site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC. J Biol Chem 1993, 268:16875-16878.
13. Briant L, Signoret N, Gaubin M, Robert-Hebmann V, Zhang X, Murali R, Greene MI, Piatier-Tonneau D, Devaux C: Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4. J Biol Chem 1997, 272:19441-19450.
14. Folks T, Powell DM, Lightfoote MM, Benn S, Martin MA, Fauci AS: Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science 1986, 231:600-602.
15. Tokunaga K, Greenberg ML, Morse MA, Cumming RI, Lyerly HK, Cullen BR: Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J Virol 2001, 75:6776-6785.
16. Cavrois M, De Noronha C, Greene WC: A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 2002, 20:1151-1154.
17. Benkirane M, Jeang KT, Devaux C: The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. Embo J 1994, 13:5559-5569.
18. Bossis G, Salinas S, Cartier C, Devaux C, Briant L: NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves 1kappaB kinases. FEBS Lett 2002, 516:257-264.
19. Dorns RW: Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology 2000, 276:229-237.
20. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ: HIV-1 cell to cell transfer across an Env-induced, actin dependent synapse. J Exp Med 2004, 199:283-293.
21. Nguyen DH, Giri B, Collins G, Taub DD: Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 2005, 304:559-569.
22. Toth PT, Ren D, Miller RJ: Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. J Pharmacol Exp Ther 2004, 310:8-17.
23. Signoret N, Blanc-Zouaoui D, Kwong PD, Sattentau QJ: Selective effects of electrostatic changes in the CD4 CDR-3-like loop on infection by different human immunodeficiency virus type 1 isolates. AIDS Res Hum Retroviruses 1996, 12:1001-1013.
24. Healey D, Dianda L, Moore JP, McDougal JS, Moore MJ, Estess P, Buck D, Kwong PD, Beverley PC, Sattentau QJ: Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med 1990, 172:1233-1242.
25. Celander D, Haseltine WA: Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses. Nature 1984, 312:159-162.
26. Levesque K, Zhao YS, Cohen EA: Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J Biol Chem 2003, 278:28346-28353.
27. Friborg J, Ladha A, Gottlinger H, Haseltine WA, Cohen EA: Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:10-22.